May 31, 2024 - Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS

Submitted by wim@als.be on Fri, 05/31/2024 - 08:49

files: 

biogen_receives_european_commission_approval_for_qalsodyr_tofersen_the_first_therapy_to_treat_a_rare_genetic_form_of_als.pdf